Webinar
Things to consider when searching for a supplier of cGMP iPSCs
Dr Mahendra Rao
Dr Mahendra Rao is CEO and Board member for panCELLa. He is an eminent scientist in the field of stem cell biology. He is internationally known for his research on human embryonic stem cells (hESCs) and has over two decades experience, not only in the academic aspects of the field, but also in government, regulation, and the industrial and clinical applications of stem cells.
As the founding director of the Centre for Regenerative Medicine (CRM) at NIH, he oversaw the generation of 400 induced Pluripotent Stem Cell (iPSC) lines slated for use in clinical therapies for a range of degenerative disorders. He has served as scientific advisor to companies and foundations such as REPROCELL, Life Technologies (now Thermo Fisher Scientific) and the New York Stem Cell Foundation (NYSCF). Dr. Rao has also worked with the U.S. Food and Drug Authority (FDA) and has served on advisory panels to the governments of the U.S., Singapore and India on policies regarding hESCs (human Embryonic Stem Cells).
On the REPROCELL blog
Latest in Clinical Capabilities
Discover the differentiation potential of induced pluripotent stem cells (iPSC) to cytotoxic NK cells, including recent advancements in research and therapy.
16 October 2024
What you should know about the FDA’s Biological License Application Process
Learn about the FDA's Biological License Application process, including submission requirements, review phases, and expedited pathways for biologics approvals.
19 September 2024
Nucleic Acid Extraction in Clinical Research
REPROCELL is revolutionizing drug discovery in clinical research through nucleic acid extraction.
08 August 2024
Data Privacy and Protection in AI for Precision Medicine
Discover how AI is revolutionizing data protection and security in precision medicine.
31 October 2023
Bias in AI for precision medicine
Without proper and due consideration in the design and delivery of new therapies and diagnostics, there is a risk that biased datasets will skew outcomes towards certain groups.
02 October 2023